NO991012L - 3,6-Ketal- og enoleter-makrolid-antibiotika - Google Patents

3,6-Ketal- og enoleter-makrolid-antibiotika

Info

Publication number
NO991012L
NO991012L NO991012A NO991012A NO991012L NO 991012 L NO991012 L NO 991012L NO 991012 A NO991012 A NO 991012A NO 991012 A NO991012 A NO 991012A NO 991012 L NO991012 L NO 991012L
Authority
NO
Norway
Prior art keywords
ketal
enol ether
macrolide antibiotics
macrolide
antibiotics
Prior art date
Application number
NO991012A
Other languages
English (en)
Other versions
NO312366B1 (no
NO991012D0 (no
Inventor
Peter Bertinato
Hengmiao Cheng
Kristin M Lundby
Road Groton
Subas M Sakya
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO991012D0 publication Critical patent/NO991012D0/no
Publication of NO991012L publication Critical patent/NO991012L/no
Publication of NO312366B1 publication Critical patent/NO312366B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19991012A 1998-03-03 1999-03-02 3,6-ketal- og enoleter-makrolidforbindelser, anvendelse derav samt farmasöytisk preparat og fremgangsmåte for fremstilling derav NO312366B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (3)

Publication Number Publication Date
NO991012D0 NO991012D0 (no) 1999-03-02
NO991012L true NO991012L (no) 1999-09-06
NO312366B1 NO312366B1 (no) 2002-04-29

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991012A NO312366B1 (no) 1998-03-03 1999-03-02 3,6-ketal- og enoleter-makrolidforbindelser, anvendelse derav samt farmasöytisk preparat og fremgangsmåte for fremstilling derav

Country Status (17)

Country Link
US (1) US6043226A (no)
EP (1) EP0941998B1 (no)
JP (1) JP3666788B2 (no)
CN (1) CN1244532A (no)
AR (1) AR016715A1 (no)
AT (1) ATE275151T1 (no)
AU (1) AU741435B2 (no)
BR (1) BR9900856A (no)
CA (1) CA2263203C (no)
DE (1) DE69919769T2 (no)
DK (1) DK0941998T3 (no)
ES (1) ES2226282T3 (no)
HU (1) HUP9900492A3 (no)
NO (1) NO312366B1 (no)
NZ (1) NZ334442A (no)
PT (1) PT941998E (no)
ZA (1) ZA991664B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EE200100245A (et) 1998-11-03 2002-10-15 Pfizer Products Inc. Uued makroliidsed antibiootikumid
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
AU2001214707A1 (en) * 2000-11-07 2002-05-21 Morphotek Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
SI1836211T1 (sl) 2004-12-21 2010-04-30 Pfizer Prod Inc Makrolidi
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
MX2010002932A (es) * 2007-09-17 2010-05-27 Enanta Pharm Inc Macrolidos de biarilo con puente en 6, 11.
WO2018193111A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193116A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193117A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
CA3060510A1 (en) 2017-04-21 2018-10-25 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
EP3612177A4 (en) 2017-04-21 2021-01-13 Lunella Biotech, Inc. TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
US12006553B2 (en) 2017-05-19 2024-06-11 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
JP6938682B2 (ja) 2017-05-19 2021-09-22 ルネラ・バイオテック・インコーポレーテッド アンチミトシン：癌幹細胞を根絶するためのミトコンドリア生合成の標的阻害薬
CU20190106A7 (es) 2017-06-26 2020-11-30 Lunella Biotech Inc Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (de) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
AU671899B2 (en) * 1993-01-26 1996-09-12 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivative
EP0918783A1 (en) * 1996-05-07 1999-06-02 Abbott Laboratories 6-o-substituted erythromycins and method for making them

Also Published As

Publication number Publication date
NO312366B1 (no) 2002-04-29
DE69919769D1 (de) 2004-10-07
JP3666788B2 (ja) 2005-06-29
ATE275151T1 (de) 2004-09-15
DE69919769T2 (de) 2005-01-27
NZ334442A (en) 2000-03-27
EP0941998A2 (en) 1999-09-15
BR9900856A (pt) 2000-04-25
ES2226282T3 (es) 2005-03-16
CA2263203C (en) 2002-09-03
ZA991664B (en) 2000-10-12
CN1244532A (zh) 2000-02-16
HUP9900492A3 (en) 2001-08-28
CA2263203A1 (en) 1999-09-03
PT941998E (pt) 2004-12-31
JPH11315093A (ja) 1999-11-16
EP0941998B1 (en) 2004-09-01
EP0941998A3 (en) 1999-10-06
HUP9900492A2 (hu) 1999-09-28
AR016715A1 (es) 2001-07-25
DK0941998T3 (da) 2004-09-20
AU741435B2 (en) 2001-11-29
NO991012D0 (no) 1999-03-02
AU1856299A (en) 1999-09-16
US6043226A (en) 2000-03-28
HU9900492D0 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
NO991012D0 (no) 3,6-Ketal- og enoleter-makrolid-antibiotika
IS5528A (is) Ný makrólíð
DE69930818D1 (de) Neuartige antibiotika
DE69838651D1 (de) Erythromycinderivate
DE69707123D1 (de) Hochgeschwindigkeitsextrusion
DE69936170D1 (de) Beatmungsgerät
FI981065L (fi) Monipistelähetys
IS5919A (is) Ný makrólíð sýklalyf
DE69913738D1 (de) Ketolid-antibiotika
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
NO20010250D0 (no) Nocatiacin-antibiotika
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
ATE246494T1 (de) Brausezubereitungen
EP0766685A4 (en) ARYL, ALKYL, ALKENYL AND ALKINYL MACROLID
DE69834049D1 (de) Kneteinrichtung
DE69934804D1 (de) Supraleiter
DE69923371D1 (de) Koaxialkabel
DE69728231D1 (de) Firststruktur
AU1974900A (en) Macrolide intermediates in the preparation of clarithromycin
DE69938275D1 (de) Sulfotransferase
DE59503848D1 (de) Copolymerisierbare Oximether
ID26522A (id) Antibiotik turunan steroid
SE9801223D0 (sv) Ed-rwu
FI980682A0 (fi) Foerfarande och anordning i en fiberbelaeggningslinje
FI980212A0 (fi) Anordning och foerfarande foer infoerande av en massabanas spets i en cellulosatork

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees